Earnings Summary

Clover Health Investments Corp.’s revenue fell -43.76% since last year same period to $505.44Mn in the Q4 2023. On a quarterly growth basis, Clover Health Investments Corp. has generated 4.85% jump in its revenue since last 3-months.

Clover Health Investments Corp.’s net profit fell -14.35% since last year same period to $-70.47Mn in the Q4 2023. On a quarterly growth basis, Clover Health Investments Corp. has generated -69.94% fall in its net profits since last 3-months.

Clover Health Investments Corp.’s net profit margin fell -103.33% since last year same period to -13.94% in the Q4 2023. On a quarterly growth basis, Clover Health Investments Corp. has generated -62.08% fall in its net profit margins since last 3-months.

Clover Health Investments Corp.’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a 50% jump from last quarter’s estimates.

Clover Health Investments Corp.’s earning per share (EPS) estimates for the current year stand at -0.07.

Clover Health Investments Corp.’s earning per share (EPS) jumped 17.65% since last year same period to -0.14 in the Q4 2023. This indicates that the Clover Health Investments Corp. has generated 17.65% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Clover Health Investments Corp.’s return on assets (ROA) stands at -0.17.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Clover Health Investments Corp.’s return on equity (ROE) stands at -0.66.